NCT03561571View on ClinicalTrials.gov

Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

May 14, 2019

Study Completion Date

May 14, 2019

Conditions
Type2 Diabetes
Interventions
OTHER

butter based breakfast

ingestion of proteins : 5 g, lipids 20 g, glucides 57 g

OTHER

Chocolate spread based breakfast

ingestion of proteins 7 g, lipids 20 g, glucides 56 g

Trial Locations (1)

69500

Hôpital Louis Pradel - department of endocrinology, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03561571 - Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes | Biotech Hunter | Biotech Hunter